Innate Immunity in multiple sclerosis white matter lesions: expression of natural cytotoxicity triggering receptor 1 (NCR1)

Abstract

BackgroundPathogenic or regulatory effects of natural killer (NK) cells are implicated in many autoimmune diseases, but evidence in multiple sclerosis (MS) and its murine models remains equivocal. In an effort to illuminate this, we have here analysed expression of the prototypic NK cell marker, NCR1 (natural cytotoxicity triggering receptor; NKp46; CD335), an activating receptor expressed by virtually all NK cells and therefore considered a pan-marker for NK cells. The only definitive ligand of NCR1 is influenza haemagglutinin, though there are believed to be others. In this study, we investigated whether there were differences in NCR1+ cells in the peripheral blood of MS patients and whether NCR1+ cells are present in white matter lesions.ResultsWe first investigated the expression of NCR1 on peripheral blood mononuclear cells and found no significant difference between healthy controls and MS patients. We then investigated mRNA levels in central nervous system (CNS) tissue from MS patients: NCR1 transcripts were increased more than 5 times in active disease lesions. However when we performed immunohistochemical staining of this tissue, few NCR1+ NK cells were identified. Rather, the major part of NCR1 expression was localised to astrocytes, and was considerably more pronounced in MS patients than controls. In order to further validate de novo expression of NCR1 in astrocytes, we used an in vitro staining of the human astrocytoma U251 cell line grown to model whether cell stress could be associated with expression of NCR1. We found up-regulation of NCR1 expression in U251 cells at both the mRNA and protein levels.ConclusionsThe data presented here show very limited expression of NCR1+ NK cells in MS lesions, the majority of NCR1 expression being accounted for by expression on astrocytes. This is compatible with a role of this cell-type and NCR1 ligand/receptor interactions in the innate immune response in the CNS in MS patients. This is the first report of NCR1 expression on astrocytes in MS tissue: it will now be important to unravel the nature of cellular interactions and signalling mediated through innate receptor expression on astrocytes.

Toll-interacting protein deficiency promotes neurodegeneration via impeding autophagy completion in high-fat diet-fed ApoE−/− mouse model

“…Tollip was shown to facilitate the transport of polyQ protein aggregates to late endosome and protect neuronal cells from death (Oguro et al, 2011). Further supporting the role of Tollip in the pathogenesis of human Alzheimer's disease, a recent study reported that Tollip expression was significantly reduced in human brain samples collected from aged and Alzheimer's individuals as compared to young individuals (Cribbs et al, 2012). Based on these findings, we aim to examine the causal connection between Tollip deficiency and neurodegeneration in vivo by employing the Tollip deficient mouse model.…”

Cytotoxic NKG2C+ CD4 T Cells Target Oligodendrocytes in Multiple Sclerosis

“…Our phenotyping results suggest that other activating receptors, such as NKp46, could also contribute to CD4 T cell-mediated cytotoxicity, although the cognate ligand remains unknown. Interestingly, NKp46 was detected on lymphoid cells in demyelinated areas, especially in active MS lesions, but colabeling has not been performed to confirm whether these cells are NK cells or T cells (38). Finally, analysis of a small subset of donors (data not shown) suggests that NKG2C + CD4 T cells are mainly effector memory cells, being CCR7…”

The role of IL-6 in neurodevelopment after prenatal stress

“…Maternal inflammatory factors, such as interleukins, may directly or indirectly alter offspring neuronal progenitors and/or microglia, a myeloid-derived class of cells in the brain (McAllister and Patterson, 2012). These maternal factors act as important mediators of embryonic brain changes; elevated maternal interleukins have been demonstrated to alter offspring behavioral and brain outcomes in animal models; specific cytokines during pregnancy have been associated with offspring neuropsychiatric disorders such as autism spectrum disorder and schizophrenia (Petitto et al, 1997; Gilmore et al, 2004; Meyer et al, 2007; Ponzio et al, 2007; AL-Ayadhi and Mostafa, 2012). …”